“From introducing a Vitamin A and D supplement during World War II, to developing the world’s first infant formula for babies allergic to cow’s milk, to being first in the U.S. to introduce the omega-3 fatty acid DHA into infant formula — which is now widely recognized as the gold standard in infant nutrition — the innovations developed by Mead Johnson for more than a century have benefited generations of children and families all over the globe,” said Robert Cleveland, Senior Vice President, Mead Johnson, North America.

The event featured hundreds of local MJN employees, executives from across North America, remarks from Evansville Mayor Stephanie Terry, a congratulatory video message from Indiana Governor Mike Braun, and the presentation of an official statement in the Congressional Record by U.S. Congressman Mark Messmer.

“Mead Johnson pioneered the field of infant nutrition,” said Governor Mike Braun. “As an entrepreneur myself, I know that businesses are all about people and I want to thank all of you for your hard work. As you celebrate 120 years, know that the state of Indiana is proud of your accomplishments.”

U.S. Representative Mark Messmer presented the company with an official statement submitted to the Congressional Record to mark the occasion. At the end of each congressional session, the Congressional Record is bound and archived in the Library of Congress, becoming a part of Congressional and national history. 

“Mead Johnson has become a world leader with a mission to nourish the world’s children for the best start in life,” said Congressman Messmer. “Today, the Enfamil family of formulas developed in Evansville supports infant nutrition across the globe, and Enfamil is the top infant formula brand recommended by pediatricians in the U.S. I commend Mead Johnson and the important work their team accomplishes in advancing pediatric nutrition and nourishing the world’s children, starting in Southern Indiana.”

Throughout its history, MJN has differentiated itself through its clinical, science-based approach, leading research to better understand the nature of human milk and applying new knowledge to design products modeled after breast milk. Some highlights are below.

• Docosahexaenoic acid (DHA): MJN was the first company in the U.S. to introduce DHA into infant formula in 2002. This omega-3 fatty acid is critical for infant brain and eye development and is now widely recognized as a standard of care in infant nutrition.
• Milk Fat Globule Membrane (MFGM): MJN’s innovative technologies and achievements in breast milk research brought MFGM components similar to those found in human milk into infant formula in 2018. MFGM is found in every drop of breast milk and plays a key role in brain growth and development.
• Probiotic LGG: In 2009 MJN was the first and continues to be the ONLY company to leverage Probiotic LGG in its Nutramigen infant formula. This probiotic supports gut health and the immune system for children who have food allergies. Today, Nutramigen is recognized by pediatricians as the #1 recommended infant formula for infants with cow’s milk allergies. 

“Beyond our heritage of innovation, we strive to not only make the best products, but also serve our communities and parents across America,” added Cleveland. “Notably, Mead Johnson was instrumental in solving the unprecedented infant formula crisis in 2022. At the time, we were the only company able to scale and implement extraordinary measures to increase infant formula speed to market by 40 percent while maintaining the highest standards of safety and quality. This swift response closed the national supply gap, ensuring families once again had reliable access to the essential nutrition on which their families depend.”

About Mead Johnson Nutrition
For over a century Mead Johnson Nutrition (MJN) has been a global leader in science-backed pediatric nutrition, combining state-of-the-art research with a commitment to the highest quality and nutritional standards to nourish the world’s children for the best start in life. Our Enfa portfolio is trusted by parents and healthcare professionals around the world to support growing families at every stage of development. Reckitt acquired MJN in 2017.

About Reckitt
We make the products people trust to care for the ones they love. We are home to some of the world’s best-loved consumer health and hygiene brands, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By creating innovative, science-backed solutions, we support people every day to live healthier lives.

Reckitt exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. This commitment goes beyond the products we make. Through our actions, we expand access to healthcare, education and economic opportunities. We support the planet by reducing waste, conserving resources and driving sustainable innovation.

We believe good health starts at home. With every action we take, we strive to make our consumers’ lives easier, cleaner and healthier, to strengthen communities and to create a more sustainable future.

Find out more or get in touch with us at www.reckitt.com/us. 

*Reckitt is the trading name of the Reckitt group of companies 

SOURCE Reckitt